XT
MRNA icon

XTX Topco’s Moderna MRNA Stock Holding History

XTX Topco’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.63M Buy
123,281
+79,623
+182% +$4.12M 0.11% 163
2026
Q1 		$2.22M Buy
+43,658
New +$2.04M 0.04% 748
2025
Q4 		– Sell
-36,755
Closed -$949K – 3621
2025
Q3 		$949K Buy
+36,755
New +$1.03M 0.05% 612
2025
Q2 		– Sell
-32,049
Closed -$909K – 2879
2025
Q1 		$909K Buy
32,049
+27,237
+566% +$967K 0.05% 622
2024
Q4 		$200K Sell
4,812
-23,444
-83% -$1.12M 0.02% 1558
2024
Q3 		$1.89M Buy
28,256
+25,400
+889% +$2.33M 0.14% 160
2024
Q2 		$339K Sell
2,856
-13,243
-82% -$1.68M 0.03% 881
2024
Q1 		$1.72M Buy
+16,099
New +$1.62M 0.23% 46
2023
Q3 		– Sell
-2,050
Closed -$249K – 1839
2023
Q2 		$249K Buy
+2,050
New +$273K 0.04% 853
2023
Q1 		– Sell
-4,327
Closed -$777K – 1524
2022
Q4 		$777K Buy
+4,327
New +$708K 0.16% 141
2022
Q3 		– Sell
-3,466
Closed -$495K – 1282
2022
Q2 		$495K Sell
3,466
-722
-17% -$103K 0.2% 116
2022
Q1 		$721K Sell
4,188
-971
-19% -$163K 0.32% 72
2021
Q4 		$1.31M Sell
5,159
-1,074
-17% -$314K 0.74% 6
2021
Q3 		$2.4M Buy
6,233
+5,299
+567% +$1.95M 0.81% 7
2021
Q2 		$219K Buy
+934
New +$167K 0.07% 522

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

XTX Topco's MRNA Position: Q2 2026 in Review

XTX Topco increased its Moderna (MRNA) stake by 182% in Q2 2026, buying an estimated $4.12M and bringing the position to 123,281 shares worth $8.63M. The position accounts for 0.11% of the portfolio, ranked #163.

XTX Topco first reported a position in MRNA in Q2 2021 and has held it in 15 quarters since. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • XTX Topco held 123,281 shares of Moderna worth $8.63M as of Q2 2026.
  • XTX Topco bought 79,623 Moderna shares in Q2 2026, an estimated $4.12M.
  • Moderna made up 0.11% of XTX Topco's portfolio in Q2 2026, its #163 holding.
  • XTX Topco first reported a position in Moderna in Q2 2021 and has held it in 15 quarters since.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.